v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues        
Life insurance premiums and other fees $ 330 $ 711 $ 1,203 $ 1,808
Interest and investment income 698 748 2,139 2,096
Owned distribution revenues 20 24 56 63
Recognized gains and (losses), net 83 211 341 (1)
Total revenues 1,131 1,694 3,739 3,966
Benefits and expenses        
Benefits and other changes in policy reserves (remeasurement gains (losses)) [1] 26 1,181 1,659 2,698
Market risk benefit (gains) losses (167) 43 (62) 148
Depreciation and amortization 191 180 539 491
Personnel costs 73 79 210 223
Other operating expenses 30 38 104 121
Interest expense 42 42 124 123
Total benefits and expenses 195 1,563 2,574 3,804
Earnings before income taxes 936 131 1,165 162
Income tax expense 195 11 250 21
Net earnings 741 120 915 141
Less: Non-controlling interests 1 2 3 4
Net earnings attributable to F&G 740 118 912 137
Less: Preferred stock dividend 4 4 13 13
Net earnings attributable to F&G common shareholders $ 736 $ 114 $ 899 $ 124
Basic        
Net earnings per share attributable to F&G common shareholders, basic (in usd per share) $ 5.71 $ 0.86 $ 6.86 $ 0.95
Diluted        
Net earnings per share attributable to F&G common shareholders, diluted (in usd per share) $ 5.48 $ 0.85 $ 6.66 $ 0.94
Weighted average shares outstanding F&G common stock, basic basis (in shares) 129 133 131 131
Weighted average shares outstanding F&G common stock, diluted basis (in shares) 135 139 137 132
[1] The remeasurement gains for the three and nine months ended September 30, 2026 were $11 million and $19 million, respectively. The remeasurement (losses) gains for the three and nine months ended September 30, 2025 were $(2) million and $30 million, respectively.